-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Latest From Biotech Now
Mito What???
Mitochondrial Disease: The Most Common Disease You’ve Probably Never Heard of… About 20 years ago, mitochondrial disease was virtually unheard of. Just 10 years ago, it was considered rare. Today, according to NORD, a disease is considered rare when less than 200,000 people are affected. Mitochondrial disease is not a single disease, but rather an entire umbrella of rare diseases. For example, Alpers disease and Barth syndrome are very different and rare forms of mitochondrial Read More >
Health
Leave a comment
Email This Post
Tags: advocacy, ALS, alzheimers, awareness, cancer, diabetes, FDA, FDASIA, genetic, health, Health Care, healthcare, lou gehrig's disease, lupus, mitochondria, mitochondrial disease, mitochondrial dysfunction, MS, Multiple sclerosis, mutation, NORD, ODTC, Orphan Drug Tax Credit, orphan drugs, Parkinson's, patient, patient advocacy, patient advocates, Patient community, patients, rare disease, Rare Disease Drug Development, rare diseases, rheumatoid arthritis
Tags: advocacy, ALS, alzheimers, awareness, cancer, diabetes, FDA, FDASIA, genetic, health, Health Care, healthcare, lou gehrig's disease, lupus, mitochondria, mitochondrial disease, mitochondrial dysfunction, MS, Multiple sclerosis, mutation, NORD, ODTC, Orphan Drug Tax Credit, orphan drugs, Parkinson's, patient, patient advocacy, patient advocates, Patient community, patients, rare disease, Rare Disease Drug Development, rare diseases, rheumatoid arthritis
Playing Detective With Checkpoint Therapies
Three words are on the lips of everyone following new developments in cancer therapies: checkpoint inhibitor drugs. Simply put, investigators believe they have figured out a way to dismantle the mechanism used by cancer cells to stay hidden from T-cells, a type of specialized immune cell. CTLA-4 is a protein on the surface of T-cells that acts as an “off” switch for the sleuthing T-cells. It signals them to remain in a resting state, kind of like Read More >
BIO Announces New Award to Honor Women in the Field Of Industrial Biotechnology
BIO recently announced the creation of the BIO Rosalind Franklin Award for Leadership in Industrial Biotechnology. This award will be presented to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. The winner will be awarded this honor at the 2014 Pacific Rim Summit on Industrial Biotech & Bioenergy, to be held December 7-9, 2014 in San Diego, California. The award is Read More >
What to Watch: Vaccines – Calling the Shots
Recently, PBS’s NOVA had an episode on the reemergence of diseases (including measles, whooping cough, and mumps) that had previously been largely eradicated in the US by vaccines, in part because nervous parents are skipping their children’s shots. At least ten percent of parents delay or skip some recommended vaccines, and one percent don’t vaccinate at all. What’s driving people away, and what are the consequences? Those are the questions explored in Vaccines — Calling Read More >
Herbicides and 2, 4-D: Cutting Through the Controversy
A number of media outlets reported on last week’s decision by the USDA to approve the use of genetically modified corn and soybean seeds that are resistant to the herbicide known as 2, 4-D. Farmers and growers, anxious for new tools in the ever-evolving fight against weeds, have been long awaiting the approval. The American Soybean Association, for example, issued a statement cheering the move and calling on the Environmental Protection Agency (EPA) to now Read More >
